Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • baboooooooz baboooooooz Oct 28, 2013 8:32 AM Flag

    08:29 EDT SNTA Synta Pharmaceuticals price target raised to $27 from $20 at Roth Capital Subscribe for More Information 08:13 EDT SNTA Synta Pharmaceuticals price target raised to $14 from $11 at JMP Securities JMP Securities increased its price target on Synta as the firm believes that recent data from a trial of the company's cancer treatment ganetespib bodes well for an ongoing trial of the drug. The firm reiterates an Outperform rating on the shares.

    08:29 EDT SNTA Synta Pharmaceuticals price target raised to $27 from $20 at Roth Capital
    Subscribe for More Information
    08:13 EDT SNTA Synta Pharmaceuticals price target raised to $14 from $11 at JMP Securities
    JMP Securities increased its price target on Synta as the firm believes that recent data from a trial of the company's cancer treatment ganetespib bodes well for an ongoing trial of the drug. The firm reiterates an Outperform rating on the shares.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SNTA
0.3793+0.0093(+2.51%)1:40 PMEDT